Cargando...
Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial
INTRODUCTION: The efficacy of a cholinesterase inhibitor, donepezil, in patients with dementia with Lewy bodies (DLB) was investigated to confirm the superiority over placebo in the 12-week, double-blind phase of this phase III study. METHODS: Patients with probable DLB (n = 142) were randomly assig...
Guardado en:
| Publicado en: | Alzheimers Res Ther |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4338565/ https://ncbi.nlm.nih.gov/pubmed/25713599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-014-0083-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|